Hands-on Workshop on ADVANCED TECHNIQUES IN ANTI-CANCER DRUG EVALUATION 3rd - 7th November, 2014  Organizing committee  25 participants will be selected. Complete registration form along with one page CV to be sent to the Organizing Secretary. Chairperson Prof. S. V. Chiplunkar Organizing Secretary Dr. Aarti Juvekar Joint Organizing Secretary Dr. Jyoti Kode Treasurer Dr. Kishore Amin  Dr. Abhijit De Dr. Arvind Ingle Dr. Pradip Chaudhari Dr. Ashok Varma Dates to remember Submission of Registration Form along with one page CV. 30th September, 2014 Intimation to selected participants. 5th October, 2014 Receiving registration Fee 10th October, 2014  Dr. Kumar Prabhash Registration fee Students – Rs. 5,000/Faculty/Scientists – Rs. 10,000/Corporate Participants – Rs. 25,000/Cheque or DD payable to “Director, ACTREC, Tata Memorial Centre” Dr. Syed Hasan   Faculty Dr. Vikram Gota Guidelines Invited speakers Dr. Ahmed Kamal, IICT, Hyderabad Dr. Matthew Ng Chau Hasien, NCCS, Singapore Dr. Vineeta Deshmukh, ICTRC, Pune Dr. Rinti Banerjee, IIT-B, Mumbai Dr. Madhu Dikshit, CDRI, Lucknow The registration fee will cover participation in the lectures/tutorials and wet lab workshop. The participants will receive a copy of the Lab manual and Certificate of Participation. Lunch and tea will be served during the workshop. Dr. Sudesh Gaidhani, CCRAS, Delhi Dr. Laxmi Adhikary, Biocon, Banglore Accommodation will be provided upon request on chargeable basis. Correspondence to: Dr. Aarti Juvekar / Dr Jyoti Kode, Secretariat, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC) Tata Memorial Centre, Sector – 22, Khargar, Navi Mumbai – 410210, M.S., India Email: [email protected]; [email protected]; [email protected] Workshop Programme Module I: Anti-Cancer Drug Screening  In vitro SRB assay  In vivo Testing  Importance of Quality Animals Module II: Immunomodulatory Activity M1  Immunophenotyping M2  Cell Cycle Arrest by PI staining  Apoptosis of Tumor cells and Lymphocytes  Cytokine Production Module III: Bioanalysis and Pharmacokinetics  Bioavailability and Drug Distribution in organs  Drug Extraction from Various Matrices (Plasma, Organ Homogenate)  Estimation of Drug by HPLC  Compartment Modelling / Winnolin Nonmem Softwares Module IV: Molecular Imaging  PET-CT/ SPECT  Optical Bioluminescence Imaging  Role in Drug Development / Validation Module V: Structural Biology  Macromolecular structure analysis using X-Ray Diffraction  BioInformatics tools for Drug Designing and Development Panel Discussion: Drug Regulatory Issues  DCGI Guidelines for Drug Development, Approval and Marketing  Regulatory Requirements for Clinical Trials